当前位置:首页 - 行情中心 - 翰宇药业(300199) - 财务分析 - 现金流量表

翰宇药业

(300199)

  

流通市值:159.89亿  总市值:189.63亿
流通股本:7.45亿   总股本:8.83亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,139,395,605.82747,075,774.04305,085,821.46902,928,792.67
  收到的税费返还4,016,961.913,846,710.221,245,829.7435,987,675.74
  收到其他与经营活动有关的现金29,985,188.5827,633,340.652,691,226.2828,455,561.78
  经营活动现金流入小计1,173,397,756.31778,555,824.91309,022,877.48967,372,030.19
  购买商品、接受劳务支付的现金413,997,924.19233,323,125.08120,441,679.82299,867,230.65
  支付给职工以及为职工支付的现金180,736,983.87120,421,842.466,105,478.99187,107,281.08
  支付的各项税费39,943,932.2729,852,780.8515,160,750.8842,284,360.86
  支付其他与经营活动有关的现金160,367,437.0889,498,721.7336,883,675.94204,209,649.32
  经营活动现金流出小计795,046,277.41473,096,470.06238,591,585.63733,468,521.91
  经营活动产生的现金流量净额378,351,478.9305,459,354.8570,431,291.85233,903,508.28
二、投资活动产生的现金流量:
  收回投资收到的现金1,040,353.291,043,894.71-2,549,989.21
  取得投资收益收到的现金2,321,178.742,321,414.89-3,288,131.02
  处置固定资产、无形资产和其他长期资产收回的现金净额599,654374,770310,000430,510
  处置子公司及其他营业单位收到的现金净额---1,854,988.23
  投资活动现金流入小计3,961,186.033,740,079.6310,0008,123,618.46
  购建固定资产、无形资产和其他长期资产支付的现金265,269,593.02203,175,188.1177,327,936.48234,353,262.95
  投资支付的现金11,200,00010,700,0005,500,000442,850
  投资活动现金流出小计276,469,593.02213,875,188.1182,827,936.48234,796,112.95
  投资活动产生的现金流量净额-272,508,406.99-210,135,108.51-82,517,936.48-226,672,494.49
三、筹资活动产生的现金流量:
  吸收投资收到的现金---100,000
  其中:子公司吸收少数股东投资收到的现金---100,000
  取得借款收到的现金1,113,355,817.48665,355,817.48581,982,817.481,577,752,645.79
  收到其他与筹资活动有关的现金403,960,998.07380,209,109.18328,182,803.62250,214,172.23
  筹资活动现金流入小计1,517,316,815.551,045,564,926.66910,165,621.11,828,066,818.02
  偿还债务支付的现金951,423,252.95695,742,757.72608,704,153.221,637,444,452.36
  分配股利、利润或偿付利息支付的现金61,745,886.1442,003,071.0422,684,987.7394,837,492.45
  支付其他与筹资活动有关的现金551,783,604.76362,164,525.08254,064,525.08119,747,239.04
  筹资活动现金流出小计1,564,952,743.851,099,910,353.84885,453,666.031,852,029,183.85
  筹资活动产生的现金流量净额-47,635,928.3-54,345,427.1824,711,955.07-23,962,365.83
四、汇率变动对现金及现金等价物的影响-5,389,871.55-3,718,791.01-1,487,542.241,481,256.88
五、现金及现金等价物净增加额52,817,272.0637,260,028.1511,137,768.2-15,250,095.16
  加:期初现金及现金等价物余额77,282,74877,282,74877,282,74892,532,843.16
  期末现金及现金等价物余额130,100,020.06114,542,776.1588,420,516.277,282,748
补充资料:
  净利润-235,639,855.52-34,026,010.77
  资产减值准备-8,114,403.33-31,252,039.51
  固定资产和投资性房地产折旧-62,660,164.24-104,665,002.81
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-62,660,164.24-104,665,002.81
  无形资产摊销-17,485,691.44-27,258,873.69
  长期待摊费用摊销-3,631,440.37-6,291,055.72
  处置固定资产、无形资产和其他长期资产的损失--1,585,559.54--617,186.97
  固定资产报废损失-225,476.13-33,093.64
  公允价值变动损失-133,524.9--153,724.57
  财务费用-36,869,196.16-98,880,040.88
  投资损失--65,398,342.27--1,346,384.37
  递延所得税-3,349,397.3-8,449,263.09
  其中:递延所得税资产减少-1,522,682.53-1,885,604.23
    递延所得税负债增加-1,826,714.77-6,563,658.86
  存货的减少--143,537,353.56--35,968,856.85
  经营性应收项目的减少--876,480.89--49,509,012.22
  经营性应付项目的增加-145,731,230.26-2,253,971.57
  现金的期末余额-114,542,776.15-77,282,748
  减:现金的期初余额-77,282,748-92,532,843.16
  现金及现金等价物的净增加额-37,260,028.15--15,250,095.16
公告日期2026-10-272026-08-212026-04-292026-04-29
审计意见(境内)标准无保留意见
TOP↑